Skip to content

Author

S. Mujwar

We have 5 of 140 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Multiscale mechanistic modeling for the rational design of novel dual-target candidates against acetylcholinesterase and NADPH oxidase: an advanced computational study

Introduction Alzheimer’s disease is a complex neurodegenerative illness strongly associated with oxidative stress, which requires immediate intervention for therapeutic agents with potent antioxidant properties. Methods In this work, novel derivatives based on benzofuran and pyrazole scaffolds were designed and assesse...

Mohamed El Fadili, M. Er-rajy, S. Mujwar et al. · 0 citations
Jul 2026

Characterization of beddomeilactone amide as bacterial DNA gyrase inhibitor: in vitro evaluation and computational insights

Analysis of the previously reported antibacterial beddomeilactone amide (3g) as a potential DNA gyrase inhibitor of S. aureus underscores potent hit (3g) as a promising candidate for the development of an antibacterial agent against S. aureus by targeting DNA gyrase.

T. Palmo, Vishwani Jamwal, Karan Goel et al. · 0 citations
Jul 2026

QbD-driven formulation development and evaluation of apigenin loaded chitosan-tethered in-situ cubosomal gel for the management of cervical cancer: A preclinical study.

The incorporation of cubosomes into a thermosensitive in-situ gel and surface modification with chitosan significantly improved formulation stability and enabled controlled drug release, highlighting the potential of CHT-AGN-CB-gel as a promising localized delivery platform for cervical cancer management, offering sust...

Muskaan Sharma, Devesh Kumar, Mohit Kumar et al. · 0 citations
Open access Aug 2026

Virtual Screening of Bacteriocins From Lactic Acid Bacteria Against Monkeypox DNA Polymerase: Sakacin P and Mundticin KS Emerge as Promising Candidates

The results indicate that bacteriocins, especially Sakacin P and Mundticin KS, can be considered potential antiviral agents against MPXV by interfering with its DNA replication mechanism.

Melisa Z Karaman, Karan Goel, F. Zanchi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.